Regulatory Approval

A landmark Medicare decision doubles payment for contrast-enhanced ultrasound, positioning the safer, cheaper alternative to challenge CT and MRI dominance.

With a $201M war chest, Muzero Acquisition Corp joins a revitalized SPAC market, targeting the next big tech-enabled company in a high-stakes search.

TeraWulf is acquiring old industrial sites in KY and MD, adding massive power capacity for the AI boom while aiming to stabilize regional energy grids.

After a brutal cold snap, Michiganders face huge energy bills. Consumers Energy is offering aid, but it highlights a growing crisis of affordability.

A $6.8M judgment against a VA claims company reveals a battle for ethics, spurring laws to protect veterans from deceptive and costly practices.

Amid rising drug price scrutiny, Red Nucleus acquires an AI-powered consultancy to revolutionize how biopharma proves the value of new medicines.

Japanese insurer Meiji Yasuda finalizes its acquisition of a top U.S. life and pension player, signaling a major strategic push into the American market.

MAPS and Columbia University launch a landmark study into MDMA-assisted couples therapy, seeking to turn decades of underground practice into a safe future.

A looming federal tax credit deadline threatens solar projects. NuGen Capital's strategic investment aims to save distressed assets and stabilize the grid.

The safety giant is launching its 35-2X Series gas ignition controls, targeting Europe and APAC's booming HVAC, ag, and cooking equipment markets.

Ensem Therapeutics expands its global trial for ETX-636, a next-gen cancer drug designed to avoid common toxicities, into China's vast patient market.

Commvault's new solution addresses rising global demand for data control, helping organizations navigate complex regulations without sacrificing cyber resilience.

Following a federal probe into a Waymo robotaxi hitting a child, the Teamsters union calls for an indefinite ban, escalating the battle over AV safety and jobs.

A landmark six-month test of an electric aircraft in Norway is complete, providing a crucial blueprint for the future of zero-emission global air travel.

A state-funded grant unites UCLA and industry to create a scientific benchmark for cannabis flavors, aiming to enhance public safety and regulatory clarity.

A life-changing treatment for a rare kidney disease is now easily accessible in France, ending a long wait for patients and bolstering a French pharma firm.

The oil & gas operator is one step from a NYSE listing, promising a 13.5% dividend yield and a major consolidation play in the mature assets market.

Corcept Therapeutics' stock plummeted and it now faces legal probes after the FDA rejected its key drug, revealing the company was warned not to apply.

Promising Phase 2 data for a potential first-in-class neuropathic corneal pain therapy to be showcased, offering new hope for a debilitating condition.

A new community survey names 2026's top privacy apps, from browsers to messaging, while revealing deep user anxiety over AI's impact on personal data.